US Patent Issued to GoldenBiotech on April 8 for "Self-retaining implantable drug delivery device" (California Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,632, issued on April 8, was assigned to GoldenBiotech LLC (Newbury Park, Calif.).

"Self-retaining implantable drug delivery device" was invented by Merrill Goldenberg (Newbury Park, Calif.) and Steven H. Rauchman (Mission Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a medical device for extended release of drugs. The device comprises a stent embedded with one or more drug depots that release of a therapeutic agent in a controlled manner. Each end of the stent may contain one or more anchors or attachment points which enable self-retention of the medical device once properly placed. The disclosed device further com...